Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0600
-0.0100 (-14.29%)
Mar 18, 2026, 12:59 PM EST
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $4.45 million as of March 19, 2026. Its market cap has decreased by -65.51% in one year.
Market Cap
4.45M
Enterprise Value
6.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 4.45M, a decrease of -95.88%. That is a compound annual growth rate of -8.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 4.82M | 71.50% |
| Dec 31, 2025 | 2.81M | -75.72% |
| Dec 31, 2024 | 11.58M | 66.86% |
| Dec 29, 2023 | 6.94M | -62.07% |
| Dec 30, 2022 | 18.31M | -27.99% |
| Dec 31, 2021 | 25.42M | 37.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nymox Pharmaceutical | 5.62M |
| GPL Holdings | 4.17M |
| Mosaic ImmunoEngineering | 3.69M |
| Galera Therapeutics | 3.64M |
| Orgenesis | 3.44M |
| Burzynski Research Institute | 3.29M |
| Clearside Biomedical | 3.23M |
| Bioxytran | 3.17M |